Zobrazeno 1 - 10
of 420
pro vyhledávání: '"Bernd C, Kieseier"'
Autor:
Laura Airas, Robert A. Bermel, Tanuja Chitnis, Hans-Peter Hartung, Jin Nakahara, Olaf Stuve, Mitzi J. Williams, Bernd C. Kieseier, Heinz Wiendl
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Bruton’s tyrosine kinase (BTK) inhibitors are an emerging class of therapeutics in multiple sclerosis (MS). BTK is expressed in B-cells and myeloid cells, key progenitors of which include dendritic cells, microglia and macrophages, integral effecto
Externí odkaz:
https://doaj.org/article/e3efcb2e0b04417cb13665a1b2416894
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Introduction/Aims Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by progressive weakness and sensory loss, often affecting patient’s ability to walk and perform activities of daily living independently. F
Externí odkaz:
https://doaj.org/article/15e507b42be345d48f21464a8d935653
Autor:
Michael Fleischer, Inn Lee, Friedrich Erdlenbruch, Lena Hinrichs, Ioannis N. Petropoulos, Rayaz A. Malik, Hans-Peter Hartung, Bernd C. Kieseier, Christoph Kleinschnitz, Mark Stettner
Publikováno v:
Journal of Neuroinflammation, Vol 18, Iss 1, Pp 1-8 (2021)
Abstract Background Immune-mediated neuropathies, such as chronic inflammatory demyelinating polyneuropathy (CIDP) are treatable neuropathies. Among individuals with diabetic neuropathy, it remains a challenge to identify those individuals who develo
Externí odkaz:
https://doaj.org/article/354f750b0fbb44cfbbae23cab9d55c66
Autor:
Ellen M. Mowry, Robert A. Bermel, James R. Williams, Tammie L. S. Benzinger, Carl de Moor, Elizabeth Fisher, Carrie M. Hersh, Megan H. Hyland, Izlem Izbudak, Stephen E. Jones, Bernd C. Kieseier, Hagen H. Kitzler, Lauren Krupp, Yvonne W. Lui, Xavier Montalban, Robert T. Naismith, Jacqueline A. Nicholas, Fabio Pellegrini, Alex Rovira, Maximilian Schulze, Björn Tackenberg, Mar Tintore, Madalina E. Tivarus, Tjalf Ziemssen, Richard A. Rudick
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the first example of a learning health system in multiple sclerosis (MS). This paper describes the initial implementation of MS PATHS and initial patient
Externí odkaz:
https://doaj.org/article/6b4c3e31f7a34f3896819caba214808c
Autor:
John-Ih Lee, Theresa Böcking, Dagny Holle-Lee, Rayaz A. Malik, Bernd C. Kieseier, Hans-Peter Hartung, Rainer Guthoff, Christoph Kleinschnitz, Mark Stettner
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: The diagnosis of trigeminal neuralgia (TN) is challenging due to the lack of objective diagnostics. Corneal confocal microscopy (CCM) is a non-invasive ophthalmic imaging technique, which allows quantification of corneal nerve fibers aris
Externí odkaz:
https://doaj.org/article/7923aa04177444ac924e06bfa1913e59
Autor:
Anne K. Mausberg, Fabian Szepanowski, Francesca Odoardi, Alexander Flügel, Christoph Kleinschnitz, Mark Stettner, Bernd C. Kieseier
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-9 (2018)
Abstract Background Autoimmune polyneuropathies are acquired inflammatory disorders of the peripheral nervous system (PNS) characterized by inflammation, demyelination, and axonal degeneration. Although the pathogenesis has not been fully elucidated,
Externí odkaz:
https://doaj.org/article/76ba0cc42f9c46798f02582b426670ca
Publikováno v:
Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-17 (2017)
Abstract Inflammatory neuropathies are rare autoimmune-mediated disorders affecting the peripheral nervous system. Considerable progress has recently been made in understanding pathomechanisms of these disorders which will be essential for developing
Externí odkaz:
https://doaj.org/article/41eadadf20964875b4fee1c0ad3429cd
Publikováno v:
Qatar Medical Journal. 2023
Autor:
Mitzi Williams, Laura Airas, Tanuja Chitnis, Sarbjit Saini, Michihiro Hide, Gordon Sussman, Jin Nakahara, Robert Bermel, Thomas Dörner, Brett Loop, Marina Ziehn, Roman Willi, Bernd C. Kieseier, Ivan Nikolaev, Sibylle Haemmerle, Artem Zharkov, Richard Siegel, Bruno Cenni, Heinz Wiendl, Marcus Maurer, Ana Giménez-Arnau, Xavier Montalban
Publikováno v:
Tuesday, April 25.
Autor:
Stephen L Hauser, Anne H Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Sven G Meuth, Paul S Giacomini, Francesco Saccà, Linda Mancione, Ronald Zielman, Morten Bagger, Ayan Das Gupta, Dieter A Häring, Valentine Jehl, Bernd C Kieseier, Ratnakar Pingili, Dee Stoneman, Wendy Su, Roman Willi, Ludwig Kappos
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England), vol 28, iss 10
Background: Ofatumumab is approved for the treatment of relapsing multiple sclerosis (RMS). Ongoing safety reporting is crucial to understand its long-term benefit–risk profile. Objective: Report the safety and tolerability of ofatumumab in RMS aft